Not a traditional drug phase: Pediatric orthopaedic implant for Fracture
Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity. Given the vital role fixation devices play in maintaining alignment, promoting healthy bone healing and preventing joint degeneration, it is essential to understand the expected lifetime outcomes of these implants, and evaluate their safety and how well it works.
Official registry: https://clinicaltrials.gov/study/NCT05361980 · University of British Columbia · enrollment listed as 4,000
What this phase means
This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.
They plan to enroll about 4,000 people at Vancouver. Taking part typically means using or being fitted with a device plus check-ins.
Official title (unrewritten)
Global Pediatric Orthopaedic Implant Safety & Efficacy Clinical Follow-up Program
Interventions: Pediatric orthopaedic implant
Primary outcome (registry wording): Device related adverse events
Who it is for (from inclusion criteria)
- Ages 0 Years to 25 Years
- Patients must be able to adhere to the required length of follow-up for the endpoints of each individual product
Who the registry excludes
- Patients with a demonstrated sensitivity to metals
- Patients with an inability to follow a post-operative regimen
Public study contact (from the registry)
Bryn Zomar, PhD
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
1 listed- BC Children's Hospital — Vancouver, British Columbia, Canada (recruiting)
FAQ about this NCT record
Is NCT05361980 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT05361980?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT05361980?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary